French biopharmaceutical company Ipsen (IPSEY) said it has initiated a share buy-back program to cover its free employee share-allocation plan and employee share plan.
The company has appointed an investment-services provider to purchase an aggregate number of Ipsen shares up to 400,000, or about 0.47% of the share capital, over a maximum period of six months.
The program is made pursuant to the authorization granted by the Company's Annual General Meeting, held on 28 May 2024.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.